✦ LIBER ✦

IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation

✍ Scribed by J.M Langrehr; R Lohmann; O Guckelberger; A.R Müller; R Raakow; N.C Nüssler; J Klupp; R Pfitzmann; S Jonas; U Settmacher; T Steinmüller; P Neuhaus

Book ID: 117230585
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 63 KB
Volume: 33
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(00)02541-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic rejection after orthotopic liver

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563

✍ J.M Langrehr; R Lohmann; R Raakow; S Jonas; J Klupp; W.O Bechstein; R Neuhaus; P 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 65 KB

9: MICA-Antibodies Predict the Risk for

9: MICA-Antibodies Predict the Risk for Acute and Chronic Rejection after Heart Transplantation

✍ I. Kaczmarek; T. Kauke; M. Schmoeckel; A. Beiras-Fernandez; P. Ueberfuhr; B. Mei 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Anti-IL-2 receptor BT563 versus placebo:

Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

✍ M Glanemann; J.M Langrehr; R Raakow; O Guckelberger; R Lohmann; J Klupp; H Lobec 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 114 KB

048 DO INDUCTIONS WITH IL-2 RECEPTOR BLO

048 DO INDUCTIONS WITH IL-2 RECEPTOR BLOCKERS INCREASE THE RISK OF NEW ONSET DIABETES ASSOCIATED WITH TRANSPLANT (NODAT)?

✍ Narayan Prasad; Dharmender Bhadauria; Raj K Sharma; Amit Gupta; Aneesh Srivastav 📂 Article 📅 2011 🏛 Medknow Publications 🌐 English ⚖ 38 KB

Interleukin-2 receptor antibody (basilix

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage

✍ Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Irene O. Ng; Ching 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

A prospective evaluation was performed to study the potential benefits of the use of interleukin-2 receptor antibody (IL-2Rab) in the induction therapy with early elimination of steroid and reduction of tacrolimus dosage in liver transplant recipients among whom 94% had chronic hepatitis B infection

786 INCREASED LEVELS OF SOLUBLE LIGANDS

786 INCREASED LEVELS OF SOLUBLE LIGANDS OF THE ACTIVATING NATURAL KILLER RECEPTOR (NKG2D) ARE INDEPENDENT RISK FACTORS FOR ADVANCED FIBROSIS IN LIVER TRANSPLANT RECIPIENTS

✍ S. Iacob; V.R. Cicinnati; G. Wu; M. Lindemann; F.M. Heinemann; V. Rebmann; P.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB